Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS fell 100.0%, free cash flow was flat and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

66.18 0.40 −0.60%
Market cap
$32.1B
P/E
50.5×
Fwd P/E
31.0×
Dividend yield
0.53%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
6 8 7 4 7 4 — — — —
P/E ratio
39.60 41.41 39.11 101.44 114.02 0.00 0.00 0.00 21.68 0.00
P/S ratio
3.74 4.23 4.02 3.89 5.15 4.72 3.68 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
— — — — — — — — — 8.16
P/FCF ratio
24.10 29.83 70.73 71.82 258.72 123.15 113.19 51.80 0.00 0.00
Beneish M-Score
(2.56) (2.65) (2.49) (2.50) (2.64) (2.72) (3.28) — — —
P/Operating CF
59.07 91.44 84.21 98.25 110.31 73.49 79.82 944.50 944.50 944.50
Dividend Safety Score
66 — — — — — — — — —
P/B ratio
1.76 1.95 1.84 1.72 2.22 1.71 1.43 1.25 1.25 1.25
Price to Tangible BV
10.30 10.44 14.40 31.92 26.92 39.35 165.37 1.25 1.25 1.25
EV/Sales
4.04 4.52 4.40 4.31 5.45 5.10 4.03 0.00 0.00 0.00
EV/EBITDA
16.46 16.97 18.38 21.07 25.11 30.44 23.86 0.00 0.00 0.00
EV/Operating CF
18.49 21.56 29.99 30.87 33.60 42.32 32.91 24.14 24.14 24.14
EV/FCF
26.04 31.83 77.52 79.59 273.90 132.92 124.08 51.63 51.63 51.63
Quick Ratio
1.17 1.58 1.21 0.97 1.25 1.30 0.97 0.81 1.03 1.00
Current Ratio
2.12 2.77 2.35 1.90 2.18 2.21 1.84 1.80 1.85 1.81
Net Debt/EBITDA
1.23 1.07 1.61 2.06 1.39 2.24 2.09 (0.07) (0.02) 0.07
Debt/Assets
15.01% 15.30% 16.00% 15.94% 14.57% 14.92% 12.58% 0.51% 0.00% 0.90%
Debt/Equity
0.22 0.22 0.23 0.24 0.21 0.22 0.18 0.01 0.01 0.01
Asset Turnover
0.34 0.33 0.32 0.31 0.30 0.25 0.27 0.26 0.49 0.23
Operating CF/Net income
2.32 2.04 1.43 3.63 3.58 (1.55) (1.40) (5.02) 4.76 (7.35)
Capex/Depreciation
(0.55) (0.55) (0.69) (0.67) (0.97) (0.34) (0.46) (0.44) 0.00 0.00
Interest Coverage
6.67 7.36 5.50 5.01 4.83 (3.89) (1.65) (10.33) (5.63) 0.63
ROE
4.50% 4.83% 4.83% 1.72% 1.97% (2.79%) (3.13%) (1.00%) 1.12% (0.71%)
ROA
3.17% 3.40% 3.31% 1.17% 1.35% (1.92%) (2.40%) (0.83%) 1.86% (0.60%)
ROIC
3.38% 3.62% 2.68% 1.80% 1.67% (1.41%) (0.53%) (0.69%) 0.00% 0.00%
Return on Tangible Assets
11.99% 12.09% 12.79% 5.17% 5.68% (8.63%) (12.99%) (5.27%) 6.36% (4.51%)
Average Days of Receivables
68.85 64.78 69.64 70.60 66.26 73.82 68.40 66.64 88.56 85.60
Research and Development Expense of Revenue
9.52% 8.84% 8.76% 8.05% 10.16% 9.85% 8.74% 8.21% 8.60% 7.57%
Selling, General and Administrative Expense of Revenue
33.16% 32.79% 33.94% 35.20% 37.10% 39.43% 37.92% 39.16% 38.22% 38.30%
Intangible Assets out of Total Assets
0.58 0.58 0.61 0.64 0.63 0.65 0.69 0.72 0.00 0.77
Share Based Compensation of Revenue
1.56% 1.51% 1.52% 1.61% 1.66% 1.54% 1.11% 0.00% 0.00% 0.00%
Graham Net Nets
(0.08) (0.06) (0.09) (0.13) (0.08) (0.12) (0.15) 0.12 0.12 0.12
Graham Number
44.73 44.84 43.06 24.75 25.99 0.00 0.00 0.00 0.00 0.00
Earnings Yield
2.53% 2.41% 2.56% 0.99% 0.88% (1.65%) (2.39%) (0.44%) 4.61% (6.67%)
Free Cash Flow Yield
4.15% 3.35% 1.41% 1.39% 0.39% 0.81% 0.88% 1.93% 0.00% 0.00%
Revenue per Share
21.09 20.05 19.18 17.74 16.92 13.97 15.38 14.65 13.95 0.00
Operating CF per Share
4.60 4.20 2.82 2.48 2.74 1.68 1.88 2.34 2.50 0.00
Capex per Share
(1.33) (1.36) (1.73) (1.52) (2.41) (1.15) (1.38) (1.46) 0.00 0.00
Free Cash Flow per Share
3.27 2.85 1.09 0.96 0.34 0.54 0.50 0.88 2.50 0.00
Cash per Share
3.26 3.70 2.22 1.99 3.21 3.18 1.68 0.47 0.35 0.00
Shareholders Equity per Share
44.68 43.59 41.83 40.04 39.30 38.49 39.54 46.37 46.83 0.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
44.68 43.59 41.83 40.04 39.30 38.49 39.54 46.37 46.83 0.00
Free Cash Flow
1,613.00 1,407.00 537.00 472.00 165.00 262.00 244.00 428.00 1,223.47 1,202.94
Working Capital
3,400.00 4,031.00 3,249.00 2,455.00 2,914.00 2,729.00 1,936.00 1,506.00 1,500.00 1,349.02
Capital Expenditures
(658.00) (670.00) (851.00) (745.00) (1,180.00) (561.00) (676.00) (712.00) (614.29) (521.57)
Net Current Asset Value
(3,071.00) (2,485.00) (3,343.00) (4,295.00) (3,357.00) (3,791.00) (4,116.00) (1,024.00) (1,066.33) (1,702.94)
EV/EBIT
30.88 31.69 40.06 55.90 77.92 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.06 0.07 0.09 0.09 0.14 0.08 0.09 0.10 0.00 0.00
Price to Operating Income
28.58 29.70 36.56 50.44 73.60 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.25 0.28 0.28 0.28 0.33 0.47 0.47 0.58 0.51 0.55
Cash ROIC
5.68% 5.02% 2.03% 1.87% 0.66% 1.07% 1.03% 1.86% 5.27% 5.15%
Accounts Receivable Turnover
5.59 5.56 5.42 5.46 5.74 4.90 5.53 4.83 4.33 4.05
Accounts Payable Turnover
5.48 5.55 5.03 4.50 4.09 4.56 5.14 5.95 5.66 5.29
Inventory Turnover
2.00 1.92 1.90 1.98 2.05 2.47 2.61 2.90 2.88 2.69
Average Days of Payables
72.59 64.14 70.35 79.18 90.57 82.13 79.05 61.09 67.69 65.60
Days of Inventory on Hand
187.44 188.18 201.41 193.95 190.47 154.14 142.83 132.69 131.24 130.46
Average Receivables
1,860.50 1,781.50 1,745.00 1,595.50 1,443.50 1,394.50 1,356.50 1,480.55 1,574.61 1,574.61
Average Payables
849.50 792.00 836.00 882.00 889.50 854.50 748.00 665.68 636.63 636.63
Average Inventory
2,329.50 2,295.00 2,215.50 2,004.00 1,771.50 1,574.50 1,472.50 1,367.96 1,249.43 1,249.43
Average Assets
30,951.00 29,980.50 29,389.50 28,582.00 27,799.50 27,627.50 27,358.50 27,351.59 13,820.59 27,437.94
Average Common Equity
21,794.00 21,088.50 20,150.50 19,466.50 19,039.00 19,062.50 20,971.00 22,769.50 22,914.71 22,914.71

Fold the line items

Columns are period end dates